Global Anti-Adhesion Barrier Gels Market Projected to Reach USD 93.42 Million by 2021, Growing at a Robust CAGR of 8.4%

Global Anti-Adhesion Barrier Gels Market

The global anti-adhesion barrier gels market is poised for significant growth, with an estimated valuation of USD 93.42 million in 2021. According to a recent study by Future Market Insights, the market is projected to expand at a compound annual growth rate (CAGR) of 8.4% during the forecast period.

Market Highlights

Leading Component:
Hyaluronic acid is at the forefront of the anti-adhesion barrier gels market, commanding a substantial share of approximately 42.2% in 2021. This naturally occurring substance is renowned for its effectiveness in preventing post-surgical adhesions, making it a preferred choice among healthcare professionals.

Key Drivers of Growth:
The increasing number of surgical procedures worldwide, along with a rising awareness of the complications associated with postoperative adhesions, is fueling the demand for anti-adhesion barrier gels. These products play a crucial role in enhancing patient outcomes by minimizing the risk of adhesions that can lead to chronic pain and additional surgeries.

Future Market Potential:
The anti-adhesion barrier gels market is anticipated to witness robust growth as advancements in technology and research continue to improve the efficacy and application of these gels. As healthcare providers seek effective solutions to enhance surgical results, the market is well-positioned for continued expansion.

An adhesion barrier as recognized by FDA is a medical implant that separates internal tissues and organs during healing and post-surgical procedures. Their main function is to reduce abnormal internal scarring also known as adhesions. Various companies manufacture anti-adhesion barrier products in the form of gels or sheets which are utilized during various surgical procedures.

Commercially available anti-adhesion materials are composed of sodium hyaluronate, Carboxymethylcellulose or even oxidized regenerated cellulose. As adhesion barriers, such as hyaluronic acid, have the highest penetration rate in orthopedic procedures. A consistent rise in the number of patients undergoing fracture repair surgery and, coronary artery bypass grafting is expected to drive the demand for these products across the globe.

During surgeries such as abdominal surgery, adhesion formation is a very common complication, wherein more than 90% of the patients develop intra-abdominal adhesions post-surgery. This leads to issues like infertility, small bowel obstruction, pelvic pain etc. Moreover, many a times, there are readmissions pertaining to these issues while many require further surgery which raises the difficulty and duration of these surgeries, thereby affecting patient’s quality of life significantly.

The use of cutting-edge technologies by surgeons to treat post-surgical adhesion has opened up new opportunities for pharmaceutical businesses to generate income. Since there is no specific medication available for the prevention of surgical adhesions, using adhesion barriers gels is an efficient strategy to lessen or avoid the incidence, extent, severity and concerns of post-surgical adhesions.

Due to the fact that adhesive barriers are the only treatment option for post-surgical adhesions, demand for adhesion barriers is anticipated to increase over the projected period.

Key Takeaways from Market Study

• Hyaluronic acid is the leading segment by product, and held 2% market value share in 2021, owing to its usage in surgeries and sport-related injuries.
• Surgical Applications held a market share of 3% in 2021 owing to a rise in surgeries in different sectors such as cardiology, neurology and others.
• By end user, hospitals are leading in the Global Anti-Adhesion Barrier Gels Industry , and are expected to continue to do so with a projected CAGR rate of 9% during the forecasted years.
• North America is considered the leading region with a value share of 5% in 2021, owing to the large number of manufacturers and growing patient pool in the region.

“Rising number surgical procedures along with growing demand for adhesion barriers post-surgery is set to propel the sales of anti-adhesion barrier gels across the globe,” says an analyst of Future Market Insights.

Market Competition

Investing in business inorganically has been the hallmark to bring strong business growth and most players in the adhesion barriers market are following this trend, which directly contributes to revenue growth, increasing product portfolio, and expanding presence and distribution network in different geographies. The general competitive environment in the Global Anti-Adhesion Barrier Gels Industry is characterized by consolidation activities such as joint ventures and new product launches.

• In January 26, 2020, Terumo Launched New Surgical Sealant AQUABRID® in EMEA Market.
• In Jan 2017, Terumo acquired brands form Abbott Laboratories. The two brands namely Angio-Seal and FemoSeal, vascular closure devices are expected to boost Terumo’s existing product portfolio in growing segments through both in-house development and external investment

Key Market Players:

• LG Chem Life Sciences Company
• Anika Therapeutics
• FzioMed, Inc.
• Normedi Nordic
• Betatech
• Bioscompass
• Klas
• Terumo
• BioRegen Biomedical
• CGBIO
• Shing Poong Pharma Co.LTD
• Hangzhou Singclean Medical Products Co., Ltd.
• Genewel
• Kyeron
• Hanohai Biological
• PlantTec Medical GmbH

A Full Report Overview

Key Market Segments Covered in the Global Anti-Adhesion Barrier Gels Industry Research

By Product:

• Hyaluronic acid
• Carboxymethylcellulose
• polyethylene oxides

By Application:

• Surgical Applications
  • Urological & Gynecological Surgeries
  • Orthopedic Surgeries
  • Abdominal surgeries
  • Neurological Surgeries
  • Cardiovascular Surgeries
  • Reconstructive and Plastic Surgeries
  • Others
• Trauma Cases

By End User:

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube